Silent Seizures May Contribute to Alzheimer's Pathology

This article originally appeared here.
Share this content:
Silent Seizures May Contribute to Alzheimer's Pathology
Silent Seizures May Contribute to Alzheimer's Pathology

TUESDAY, May 2, 2017 (HealthDay News) -- Undetected seizures may contribute to some symptoms associated with Alzheimer's disease, such as confusion, according to research published online May 1 in Nature Medicine.

The study involved two women, both in their 60s with signs and symptoms of Alzheimer's disease. Neither of the women had a history of seizures. The researchers assessed mesial temporal activity using intracranial foramen ovale electrodes.

The team detected clinically silent hippocampal seizures and epileptiform spikes during sleep. One of the women experienced three seizures during a 12-hour period, with none producing any visible symptoms. Anticonvulsant medication eliminated the seizure-like activity. She experienced only one episode of confusion over the next year, which occurred after missing several doses of the medication. The other woman had similar electrode recordings and discontinued anticonvulsant medication due to effects on mood.

"Our findings confirmed the presence of serious dysfunction of the neuronal networks affected by Alzheimer's disease and confirmed our hypothesis that epileptic phenomena are an important component of that disturbance," senior author Andrew Cole, M.D., of the Massachusetts General Hospital Epilepsy Service in Boston, said in a hospital news release. "We now have to study more individuals to validate this finding and understand how prevalent it is in Alzheimer's patients, whether it occurs in other neurodegenerative disorders and how it responds to treatment."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Actemra to Treat Giant Cell Arteritis

FDA Approves Actemra to Treat Giant Cell Arteritis

New indication provides the first FDA-approved therapy specific to this type of vasculitis

Trends in Teen Binge Drinking Still Raise Concerns

Trends in Teen Binge Drinking Still Raise Concerns

Even though frequent binge drinking among adolescents has dropped in past 25 years

ATS: First Abx Rx Doesn't Work for 25 of Pneumonia Cases

ATS: First Abx Rx Doesn't Work for ~25% ...

One in four adult patients do not respond to initial prescription of antibiotic treatment

is free, fast, and customized just for you!

Already a member?

Sign In Now »